ArticleFrontiers in immunology2026

Ruxolitinib for rheumatic disease-associated macrophage activation syndrome in children: a retrospective cohort study.

Xiaona Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.